Matches in Wikidata for { <http://www.wikidata.org/entity/Q67133932> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q67133932 description "clinical trial" @default.
- Q67133932 description "ensayu clínicu" @default.
- Q67133932 description "klinisch onderzoek" @default.
- Q67133932 description "клінічне випробування" @default.
- Q67133932 description "կլինիկական փորձարկում" @default.
- Q67133932 name "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 name "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 type Item @default.
- Q67133932 label "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 label "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 prefLabel "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 prefLabel "Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer" @default.
- Q67133932 P1132 Q67133932-C7EBA3C5-EA08-4BFF-BBE9-13F8CB88C5BF @default.
- Q67133932 P1476 Q67133932-C589DD40-9F3D-45DA-A414-6F268870E226 @default.
- Q67133932 P17 Q67133932-FC1FC4D3-0A3A-419B-A5A0-319786820362 @default.
- Q67133932 P2899 Q67133932-6730B5B5-1CBD-41DA-AB6E-F1CB36B86CD4 @default.
- Q67133932 P3098 Q67133932-2FFF48A3-6172-47EF-BECC-3E110CFA056B @default.
- Q67133932 P31 Q67133932-57E12E97-ECDC-40CD-B2D4-A08A80ACEA35 @default.
- Q67133932 P4844 Q67133932-1769C2AD-8D4B-473F-8E64-06C082F1B9F4 @default.
- Q67133932 P4844 Q67133932-604D8786-137D-4E69-8C81-9D97876CACF7 @default.
- Q67133932 P580 Q67133932-89D7E745-C974-494E-AFCA-B114170F7FD7 @default.
- Q67133932 P582 Q67133932-230DC10C-538C-4EAF-9699-FFB2C16E97A8 @default.
- Q67133932 P6099 Q67133932-2F3B221E-0A99-4725-A521-9024FBCABE7F @default.
- Q67133932 P8363 Q67133932-82CB4DAA-1092-4AD3-8BA2-43A6592A3308 @default.
- Q67133932 P921 Q67133932-03480CA5-B5F5-4981-862B-912402235894 @default.
- Q67133932 P1132 "+114" @default.
- Q67133932 P1476 "A Phase 1, Open-label, Multicenter, Safety Study of Nivolumab (Bms-936558) in Combination With Nab-pacitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-paclitaxel/Carboplatin in Stage Iiib/iv Non-small Cell Lung Cancer or Nab-paclitaxel in Metastastic Breast Cancer" @default.
- Q67133932 P17 Q30 @default.
- Q67133932 P2899 "+18" @default.
- Q67133932 P3098 "NCT02309177" @default.
- Q67133932 P31 Q30612 @default.
- Q67133932 P4844 Q415588 @default.
- Q67133932 P4844 Q423762 @default.
- Q67133932 P580 "2015-01-12T00:00:00Z" @default.
- Q67133932 P582 "2018-09-12T00:00:00Z" @default.
- Q67133932 P6099 Q5452194 @default.
- Q67133932 P8363 Q78089383 @default.
- Q67133932 P921 Q7041828 @default.